Skip to Content

Genetic Technologies Ltd GNTLF

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

GNTLF is trading at a 56% discount.
Price
$0.07
Fair Value
$1.94
Uncertainty
Extreme
1-Star Price
$1.24
5-Star Price
$6.27
Economic Moat
Wfp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GNTLF is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
$0.00 /
Market Cap
Volume/Avg
/ 11

Key Statistics

Price/Earnings (Normalized)
14.20
Price/Sales
1.22
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Core
Total Number of Employees
60

Valuation

Metric
GNTLF
Price/Earnings (Normalized)
14.20
Price/Book Value
1.09
Price/Sales
1.22
Price/Cash Flow
Price/Earnings
GNTLF

Financial Strength

Metric
GNTLF
Quick Ratio
1.42
Current Ratio
1.67
Interest Coverage
−487.77
Quick Ratio
GNTLF

Profitability

Metric
GNTLF
Return on Assets (Normalized)
−73.31%
Return on Equity (Normalized)
−105.93%
Return on Invested Capital (Normalized)
−102.40%
Return on Assets
GNTLF
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncFwzqxsdpcLtwz$209.3 Bil
DHR
Danaher CorpWwvqsgdzVdqmm$174.8 Bil
IQV
IQVIA Holdings IncFksybqlbXzkkrk$41.3 Bil
IDXX
IDEXX Laboratories IncXhnyxvcmNtbtbrz$39.6 Bil
A
Agilent Technologies IncDscpfnqkcjVltfd$39.2 Bil
MTD
Mettler-Toledo International IncQyvrlxhdDdqstbc$25.5 Bil
ICLR
Icon PLCFxbwqjvQslgpks$24.6 Bil
ILMN
Illumina IncGdgwztxdZrnrdc$18.6 Bil
WAT
Waters CorpMsvtgxjwvHhyv$18.0 Bil
LH
Laboratory Corp of America HoldingsKmxbhpwsJvyysr$17.1 Bil

Sponsor Center